FBP2 Antibodies

Santa Cruz Biotechnology provides a broad selection of FBP2 monoclonal antibodies for investigating fructose-1,6-bisphosphatase 2 (FBP2) in various biological processes. FBP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBP2 is a key enzyme in gluconeogenesis, playing a crucial role in regulating glucose metabolism and energy homeostasis. Its function is vital for maintaining blood sugar levels, particularly during fasting or intense exercise. Dysregulation of FBP2 has been implicated in metabolic disorders, making it an important target for research in diabetes and obesity. Understanding FBP2's role in glucose metabolism requires reliable and specific detection methods. Researchers can utilize FBP2 monoclonal antibodies to examine expression patterns across different tissues and cellular conditions. Advanced research with FBP2 monoclonal antibodies enables investigation of metabolic pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.